IPI Resident Scholar Dr. Merrill Matthews describes some of the hurdles of prescription drug development, why the development of the Covid-19 vaccines is such a success story, and what we might learn from this experience. With comments by IPI president Tom Giovanetti.
2021_03_04 Policy Basics Prescription Drug Development